• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年因素对老年软组织肉瘤患者手术及预后结果的影响。

Impact of geriatric factors on surgical and prognostic outcomes in elderly patients with soft-tissue sarcoma.

作者信息

Tsuda Yusuke, Ogura Koichi, Kobayashi Eisuke, Hiruma Toru, Iwata Shintaro, Asano Naofumi, Kawai Akira, Chuman Hirokazu, Ishii Takeshi, Morioka Hideo, Kobayashi Hiroshi, Kawano Hirotaka

机构信息

Department of Orthopedic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo.

Division of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo.

出版信息

Jpn J Clin Oncol. 2017 May 1;47(5):422-429. doi: 10.1093/jjco/hyx016.

DOI:10.1093/jjco/hyx016
PMID:28201801
Abstract

OBJECTIVE

Patients aged ≥65 years requiring surgery for soft-tissue sarcoma are a concern in an aging society. We aimed to reveal the association of clinical/geriatric factors with survival period or postoperative events in such patients who underwent surgery.

METHODS

We enrolled patients aged ≥65 years who underwent surgery for localized soft-tissue sarcoma at five institutions. We retrospectively collected clinical/geriatric factors and laboratory data, and analyzed their association with outcomes using univariate and multivariate analyses.

RESULTS

Among the 202 patients included, mean age at presentation was 73 years. Surgical margin was R0 in 139 patients (69%). The Eastern Cooperative Oncology Group performance status was ≥2 in 15 (7%). Thirty patients (15%) showed thinness (body mass index <18.49 kg/cm2). High-sensitivity-modified Glasgow prognostic score ≥1 was seen in 52 patients (26%). Multivariate analysis showed that R1 surgical margin was significantly correlated with poor sarcoma-specific survival (hazard ratio for R1 vs. R0, 3.17; P = 0.001) and event-free survival (hazard ratio for R1 vs. R0, 2.56; P < 0.001). Higher Eastern Cooperative Oncology Group performance status was significantly associated with poor sarcoma-specific survival (hazard ratio for ≥2 vs. 0 or 1, 2.15; P = 0.038), and higher sensitivity-modified Glasgow prognostic score was significantly associated with poor event-free survival (hazard ratio for ≥1 vs. 0, 1.74; P = 0.046). Severe thinness (body mass index <16.00) was a risk factor for postoperative events (odds ratio for body mass index <16.00 vs. ≥16.00, 8.15, P = 0.010).

CONCLUSIONS

Negative surgical margin was associated with better survival. Coexisting conditions had an impact on outcomes in elderly soft-tissue sarcoma patients.

摘要

目的

在老龄化社会中,年龄≥65岁需要接受软组织肉瘤手术的患者备受关注。我们旨在揭示此类接受手术治疗的患者的临床/老年因素与生存期或术后事件之间的关联。

方法

我们纳入了在五家机构接受局限性软组织肉瘤手术的年龄≥65岁的患者。我们回顾性收集了临床/老年因素和实验室数据,并使用单因素和多因素分析来分析它们与预后的关联。

结果

在纳入的202例患者中,就诊时的平均年龄为73岁。139例患者(69%)手术切缘为R0。东部肿瘤协作组体能状态≥2的患者有15例(7%)。30例患者(15%)体重过轻(体重指数<18.49kg/cm²)。52例患者(26%)高敏改良格拉斯哥预后评分≥1。多因素分析显示,R1手术切缘与较差的肉瘤特异性生存期显著相关(R1与R0相比的风险比,3.17;P = 0.001)以及无事件生存期(R1与R0相比的风险比,2.56;P < 0.001)。较高的东部肿瘤协作组体能状态与较差的肉瘤特异性生存期显著相关(≥2与0或1相比的风险比,2.15;P = 0.038),较高的高敏改良格拉斯哥预后评分与较差的无事件生存期显著相关(≥1与0相比的风险比,1.74;P = 0.046)。严重体重过轻(体重指数<16.00)是术后事件的危险因素(体重指数<16.00与≥16.00相比的比值比,8.15,P = 0.010)。

结论

阴性手术切缘与更好的生存期相关。并存疾病对老年软组织肉瘤患者的预后有影响。

相似文献

1
Impact of geriatric factors on surgical and prognostic outcomes in elderly patients with soft-tissue sarcoma.老年因素对老年软组织肉瘤患者手术及预后结果的影响。
Jpn J Clin Oncol. 2017 May 1;47(5):422-429. doi: 10.1093/jjco/hyx016.
2
Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors.腹膜后和深部躯干软组织肉瘤综合治疗的长期结果:预后因素分析
Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):514-9. doi: 10.1016/s0360-3016(02)02942-5.
3
Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study.老年软组织肉瘤患者完全切除后的良好结果:日本肌肉骨骼肿瘤学组研究。
Eur J Surg Oncol. 2014 Jan;40(1):49-54. doi: 10.1016/j.ejso.2013.09.004. Epub 2013 Sep 13.
4
Impact of margin status and local recurrence on soft-tissue sarcoma outcomes.边缘状态和局部复发对软组织肉瘤结局的影响。
J Bone Joint Surg Am. 2013 Oct 16;95(20):e151. doi: 10.2106/JBJS.L.01149.
5
Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?局部复发、远处转移和死亡的多状态模型能否改善软组织肉瘤患者结局的预测?
Clin Orthop Relat Res. 2017 May;475(5):1427-1435. doi: 10.1007/s11999-017-5232-x. Epub 2017 Jan 12.
6
The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery.保守手术治疗局部原发性软组织肉瘤术后放疗的疗效
Radiat Oncol. 2016 Feb 25;11:25. doi: 10.1186/s13014-016-0605-y.
7
Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence.四肢软组织肉瘤:原发手术和复发后再次手术时适当的手术切缘对预后的影响。
Ann Surg Oncol. 2010 Aug;17(8):2102-11. doi: 10.1245/s10434-010-0997-0. Epub 2010 Mar 9.
8
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.奥拉单抗与多柔比星联合治疗与多柔比星单药治疗软组织肉瘤的疗效比较:一项开放标签的1b期和随机2期试验。
Lancet. 2016 Jul 30;388(10043):488-97. doi: 10.1016/S0140-6736(16)30587-6. Epub 2016 Jun 9.
9
Intraoperative radiotherapy for primary and locally recurrent soft tissue sarcoma: morbidity and long-term prognosis.原发性和局部复发性软组织肉瘤的术中放疗:发病率和长期预后
Eur J Surg Oncol. 2000 Nov;26 Suppl A:S21-4.
10
The prognostic role of the preoperative systemic immune-inflammation index and high-sensitivity modified Glasgow prognostic score in patients after radical operation for soft tissue sarcoma.术前全身免疫炎症指数和高敏改良格拉斯哥预后评分在软组织肉瘤根治术后患者中的预后作用。
Eur J Surg Oncol. 2020 Aug;46(8):1496-1502. doi: 10.1016/j.ejso.2020.05.026. Epub 2020 Jun 11.

引用本文的文献

1
Oncological Outcomes and Postoperative Complications for Localized Soft Tissue Sarcomas of the Extremities and Trunk Wall in Patients Aged 85 Years or Older.85岁及以上患者四肢和躯干壁局限性软组织肉瘤的肿瘤学结局及术后并发症
Cancers (Basel). 2025 Jun 11;17(12):1940. doi: 10.3390/cancers17121940.
2
Surgical Treatment and Prognosis of Soft Tissue Sarcoma in Patients Aged 85 Years and Older.85岁及以上患者软组织肉瘤的外科治疗与预后
In Vivo. 2025 May-Jun;39(3):1661-1668. doi: 10.21873/invivo.13967.
3
The Prognostic Significance of Surgical Treatment for Excessive Elderly Soft Tissue Sarcoma Patients over 90 Years Old: A Clinicopathological Study of 16 Cases.
90 岁以上超高龄软组织肉瘤患者外科治疗的预后意义:16 例临床病理研究。
Med Princ Pract. 2024;33(5):424-430. doi: 10.1159/000539728. Epub 2024 Jun 10.
4
Survival and Results after Resection and Reconstruction with Megaprosthesis at the Hip in Octogenarians.老年患者髋关节置换术后使用大假体进行切除与重建的生存率及结果
J Clin Med. 2023 Dec 17;12(24):7740. doi: 10.3390/jcm12247740.
5
C‑reactive protein and related predictors in soft tissue sarcoma (Review).软组织肉瘤中的C反应蛋白及相关预测指标(综述)
Mol Clin Oncol. 2023 Nov 24;20(1):6. doi: 10.3892/mco.2023.2704. eCollection 2024 Jan.
6
Clinical course and features of soft tissue sarcomas in geriatric patients: a single-center experience.老年患者软组织肉瘤的临床过程和特征:单中心经验。
J Int Med Res. 2023 Mar;51(3):3000605231159319. doi: 10.1177/03000605231159319.
7
Wide excision alone for elderly patients aged > 70 years old with soft tissue sarcomas.对于年龄>70 岁的软组织肉瘤老年患者,仅行广泛切除术。
Medicine (Baltimore). 2022 Sep 9;101(36):e30127. doi: 10.1097/MD.0000000000030127.
8
Hypofractionated preoperative radiotherapy for high risk soft tissue sarcomas in a geriatric patient population.老年软组织肉瘤高危患者的短程术前放疗。
Radiol Oncol. 2021 Nov 19;55(4):459-466. doi: 10.2478/raon-2021-0038.
9
Extremities Soft Tissue Sarcomas, more Common and as Dangerous as Bone Sarcomas.肢体软组织肉瘤比骨肉瘤更常见且同样危险。
Rev Bras Ortop (Sao Paulo). 2021 Aug;56(4):419-424. doi: 10.1055/s-0040-1712136. Epub 2020 Sep 25.
10
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.基于生长调节指数的GEISTRA评分作为晚期软组织肉瘤患者曲贝替定疗效的新预后工具:西班牙肉瘤研究小组(GEIS)的回顾性研究
Cancers (Basel). 2021 Feb 14;13(4):792. doi: 10.3390/cancers13040792.